Yi Nong, Ph.D.

Affiliations: 
 
Google:
"Yi Nong"
Mean distance: 15.63 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang H, Nong Y, Bazan F, et al. (2010) Norbin: A promising central nervous system regulator. Communicative & Integrative Biology. 3: 487-90
Netzer WJ, Powell C, Nong Y, et al. (2010) Lowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse model. Plos One. 5: e10943
Wang H, Westin L, Nong Y, et al. (2009) Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signaling. Science (New York, N.Y.). 326: 1554-7
Tekinay AB, Nong Y, Miwa JM, et al. (2009) A role for LYNX2 in anxiety-related behavior. Proceedings of the National Academy of Sciences of the United States of America. 106: 4477-82
Hemstapat K, Da Costa H, Nong Y, et al. (2007) A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors. The Journal of Pharmacology and Experimental Therapeutics. 322: 254-64
Chen Y, Nong Y, Goudet C, et al. (2007) Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses. Molecular Pharmacology. 71: 1389-98
Galici R, Jones CK, Hemstapat K, et al. (2006) Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice. The Journal of Pharmacology and Experimental Therapeutics. 318: 173-85
Wen D, Nong Y, Morgan JG, et al. (2006) A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells. The Journal of Pharmacology and Experimental Therapeutics. 317: 989-1001
Rodriguez AL, Nong Y, Sekaran NK, et al. (2005) A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators. Molecular Pharmacology. 68: 1793-802
Snyder EM, Nong Y, Almeida CG, et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nature Neuroscience. 8: 1051-8
See more...